T Azarian, PK Mitchell, M Georgieva… - PLoS …, 2018 - journals.plos.org
Streptococcus pneumoniae serotype 3 remains a significant cause of morbidity and mortality worldwide, despite inclusion in the 13-valent pneumococcal conjugate vaccine (PCV13) …
R Wilson, JM Cohen, M Reglinski, RJ Jose… - PLoS …, 2017 - journals.plos.org
Naturally acquired immunity against invasive pneumococcal disease (IPD) is thought to be dependent on anti-capsular antibody. However nasopharyngeal colonisation by …
B cells play a central role in adaptive immune processes, mainly through the production of antibodies. The maturation of the B cell system with age is poorly studied. We extensively …
Streptococcus pneumoniae (pneumococcus) is a nasopharyngeal commensal and respiratory pathogen. This study characterises the immunoglobulin G (IgG) repertoire …
MS Kelly, C Plunkett, Y Yu, JN Aquino… - The ISME …, 2022 - academic.oup.com
Streptococcus pneumoniae (pneumococcus) is a leading cause of severe infections among children and adults. Interactions between commensal microbes in the upper respiratory tract …
Streptococcus pneumoniae (the pneumococcus) is a nasopharyngeal commensal and respiratory pathogen. Most isolates express a capsule, the species-wide diversity of which …
U Binsker, JA Lees, AJ Hammond… - The Journal of clinical …, 2020 - Am Soc Clin Investig
Successful infection by mucosal pathogens requires overcoming the mucus barrier. To better understand this key step, we performed a survey of the interactions between human …